Ogden Christopher 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Ogden Christopher（CIK 1914523）在 1 家公司共报告 6 笔 SEC Form 4 内部人交易（最近一笔 2026-06-17）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-17 | CytomX Therapeutics, Inc. (CTMX) | Chief Financial Officer | 卖出 | 1,624 | $4,953 |
| 2026-03-19 | CytomX Therapeutics, Inc. (CTMX) | Chief Financial Officer | 卖出 | 19,323 | $124,054 |
| 2026-02-04 | CytomX Therapeutics, Inc. (CTMX) | Chief Financial Officer | 买入 | 90,000 | $0 |
| 2025-06-17 | CytomX Therapeutics, Inc. (CTMX) | Chief Financial Officer | 卖出 | 1,641 | $4,841 |
| 2025-06-17 | CytomX Therapeutics, Inc. (CTMX) | Chief Financial Officer | 买入 | 37,500 | $0 |
| 2025-06-17 | CytomX Therapeutics, Inc. (CTMX) | Chief Financial Officer | 卖出 | 10,614 | $28,552 |
来源：SEC Form 4 申报文件 · 截至 2026-06-17